What odds do you place on the safety being ok? I listened to one of the recent presentations and management seems highly competent and seemed confident that it would be fine. Thanks.
My wife works for big Pharma, pretty high up the chain regarding trials. She told me to buy this when it was in the high 20's and I didn't and watched it go all the way to 80's.
The crazy selloff was stupid... She like Portolo also. Many big Pharma are using abixiban and this could be a buyout as well...
ESPR is in a crowded space, but the first Esperion was bought by Pfizer and this one could be bought by big pharma as well
Market Data 
Markets 
AI
